Compare TTD & LNTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TTD | LNTH |
|---|---|---|
| Founded | 2009 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Computer Software: Programming Data Processing | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.5B | 6.6B |
| IPO Year | 2016 | 2014 |
| Metric | TTD | LNTH |
|---|---|---|
| Price | $12.69 | $99.97 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 34 | 6 |
| Target Price | $46.22 | ★ $87.00 |
| AVG Volume (30 Days) | ★ 16.4M | 922.1K |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 15.38 | N/A |
| EPS | 0.22 | ★ 2.91 |
| Revenue | ★ $2,896,284,000.00 | $343,374,000.00 |
| Revenue This Year | $13.94 | N/A |
| Revenue Next Year | $12.61 | $14.19 |
| P/E Ratio | $60.16 | ★ $34.36 |
| Revenue Growth | ★ 18.47 | 3.62 |
| 52 Week Low | $12.83 | $49.67 |
| 52 Week High | $55.10 | $111.86 |
| Indicator | TTD | LNTH |
|---|---|---|
| Relative Strength Index (RSI) | N/A | 40.87 |
| Support Level | N/A | $99.92 |
| Resistance Level | N/A | $101.43 |
| Average True Range (ATR) | 0.00 | 0.44 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 0.00 | 0.93 |
The Trade Desk provides a self-service platform that helps advertisers and ad agencies programmatically find and purchase digital ad inventory (display, video, audio, and social) on devices like computers, smartphones, and connected TVs. The firm's platform is referred to as a DSP in the digital ad industry, and it generates revenue from fees based on a percentage of what its clients spend on advertising, sometimes referred to as a "take rate."
Lantheus Holdings Inc is a radiopharmaceutical-focused company committed to enabling clinicians to Find, Fight and Follow disease to deliver patient outcomes. The Company classifies its products into Radiopharmaceutical Oncology, Precision Diagnostics, and Strategic Partnerships and Other Revenue. Its products help healthcare professionals Find, Fight and Follow cancer and diseases and are used by physicians and technologists in clinical settings. The Company produces and markets its products in the United States, mainly to hospitals, independent imaging centers and government facilities, and sells outside the United States through direct and third-party distribution relationships and licensing arrangements in Europe, Canada, Australia, Asia-Pacific, Central America and South America.